Published in Mol Nutr Food Res on October 01, 2008
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta (2012) 1.26
Polyphenols and aging. Curr Aging Sci (2010) 1.06
The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev (2010) 1.00
Novel strategies targeting cancer stem cells through phytochemicals and their analogs. Drug Deliv Transl Res (2013) 0.85
Targeting CSC-related miRNAs for cancer therapy by natural agents. Curr Drug Targets (2012) 0.83
Examining the genomic influence of skin antioxidants in vitro. Mediators Inflamm (2010) 0.80
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
The KEGG resource for deciphering the genome. Nucleic Acids Res (2004) 53.05
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60
The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol (2004) 24.63
MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol (2003) 20.83
A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics (2001) 16.47
GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet (2002) 14.69
Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset. Genome Biol (2005) 8.32
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell (1993) 7.14
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development (2004) 6.21
Why drinking green tea could prevent cancer. Nature (1997) 3.78
A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc Natl Acad Sci U S A (2002) 2.58
A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol (2004) 2.46
Angiogenesis inhibited by drinking tea. Nature (1999) 2.31
Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J Nat Prod (1996) 1.88
Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell (2006) 1.81
Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst (1994) 1.74
Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest (1997) 1.67
A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc Natl Acad Sci U S A (2002) 1.64
The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation. Development (2000) 1.60
Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling. Dev Dyn (2006) 1.54
Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer (2001) 1.43
Wnt signal transduction and the formation of the myocardium. Dev Biol (2006) 1.43
Green tea and cancer in humans: a review of the literature. Nutr Cancer (1998) 1.39
VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function. J Biol Chem (2004) 1.38
The Frizzled family: receptors for multiple signal transduction pathways. Genome Biol (2004) 1.34
Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem (1997) 1.32
The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress. Hepatology (1999) 1.32
A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res (1988) 1.32
Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology (Bethesda) (2006) 1.30
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer (2001) 1.26
Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev Biol (1991) 1.24
Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells. Br J Pharmacol (2003) 1.19
Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett (2002) 1.17
Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res (2005) 1.16
A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. DNA Cell Biol (2003) 1.16
Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol (2001) 1.16
cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis (2001) 1.15
Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J Biol Chem (2004) 1.15
Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol (2003) 1.12
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer (2006) 1.07
Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J (2002) 1.07
Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray. Mol Cancer Ther (2004) 1.06
Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer (1999) 1.01
Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer (2003) 0.99
Id-1 promotes proliferation of p53-deficient esophageal cancer cells. Int J Cancer (2006) 0.99
The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem J (2002) 0.93
Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. J Agric Food Chem (1999) 0.91
Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets. Carcinogenesis (1998) 0.90
Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutr Cancer (2001) 0.90
Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice. Cancer Res (1997) 0.87
Gene expression profile in human prostate LNCaP cancer cells by (--) epigallocatechin-3-gallate. Cancer Lett (2002) 0.83
Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol Pharm Bull (2001) 0.80
Mixed linear model approach adapted for genome-wide association studies. Nat Genet (2010) 8.47
Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes (2008) 4.20
Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis. Sci Signal (2009) 2.57
An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation. Cancer Res (2010) 2.14
The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Clin Chem (2007) 2.03
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr (2009) 1.47
Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA (2005) 1.36
A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. Pharmacogenet Genomics (2012) 1.35
Lifespan modification by glucose and methionine in Drosophila melanogaster fed a chemically defined diet. Age (Dordr) (2006) 1.33
PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. Diabetes (2007) 1.31
Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension (2012) 1.28
The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site. PLoS One (2011) 1.28
A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics (2011) 1.25
CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids. Am J Clin Nutr (2009) 1.24
Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res (2005) 1.23
APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations. Arch Intern Med (2009) 1.22
Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr (2003) 1.20
A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J Nutr (2011) 1.20
Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr (2009) 1.20
Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation (2009) 1.20
A demonstration of the transition from ready-to-hand to unready-to-hand. PLoS One (2010) 1.18
Unique dietary patterns and chronic disease risk profiles of adult men: the Framingham nutrition studies. J Am Diet Assoc (2005) 1.17
Fusion versus Bryan Cervical Disc in two-level cervical disc disease: a prospective, randomised study. Int Orthop (2008) 1.17
Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J Nutr (2007) 1.15
ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity (Silver Spring) (2008) 1.15
Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes (2011) 1.13
Molecular mechanisms of hypolipidemic effects of curcumin. Biofactors (2013) 1.10
APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med (Berl) (2007) 1.10
Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study. Diabetes Care (2008) 1.09
Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest (2007) 1.09
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer (2006) 1.07
The effects of ABCG5/G8 polymorphisms on plasma HDL cholesterol concentrations depend on smoking habit in the Boston Puerto Rican Health Study. J Lipid Res (2008) 1.06
Posterior lumbar interbody fusion versus posterolateral fusion in spondylolisthesis: a prospective controlled study in the Han nationality. Int Orthop (2008) 1.06
Chemical structure of flavonols in relation to modulation of angiogenesis and immune-endothelial cell adhesion. J Nutr Biochem (2005) 1.05
Genetic variants in human CLOCK associate with total energy intake and cytokine sleep factors in overweight subjects (GOLDN population). Eur J Hum Genet (2009) 1.04
Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey, 2003-2004. Am J Epidemiol (2009) 1.03
Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J Endocrinol (2010) 1.02
Dietary polyphenols, inflammation, and cancer. Nutr Cancer (2009) 1.02
Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. J Nutr (2009) 1.01
Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am J Hum Genet (2012) 1.01
Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites. BMC Genet (2009) 1.01
Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study. J Lipid Res (2010) 1.00
Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer (2003) 0.99
Erythrocyte cell membrane phospholipid levels compared against reported dietary intakes of polyunsaturated fatty acids in pregnant Mexican women. Public Health Nutr (2002) 0.99
Superiority of the Bryan(®) disc prosthesis for cervical myelopathy: a randomized study with 3-year followup. Clin Orthop Relat Res (2011) 0.99
Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations. PLoS One (2012) 0.99
A Database of Gene-Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular Disease and Type 2 Diabetes. J Data Mining Genomics Proteomics (2011) 0.98
Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults. Atherosclerosis (2010) 0.98
Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study. Pharmacogenet Genomics (2009) 0.97
Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects on cyclooxygenase-2 and phospholipase A2. J Nutr (2005) 0.95
Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits. PLoS One (2013) 0.95
Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production. Atherosclerosis (2005) 0.94
Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states. Am J Clin Nutr (2008) 0.94
Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity. Hum Genet (2012) 0.93
Clinical and radiographic reports following cervical arthroplasty: a 24-month follow-up. Int Orthop (2008) 0.93
Vitamin E supplementation suppresses macrophage accumulation and endothelial cell expression of adhesion molecules in the aorta of hypercholesterolemic rabbits. Atherosclerosis (2004) 0.92
The antiatherogenic potential of oat phenolic compounds. Atherosclerosis (2004) 0.91
Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res (2006) 0.91
Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study. Atherosclerosis (2009) 0.91
Avenanthramides, polyphenols from oats, inhibit IL-1beta-induced NF-kappaB activation in endothelial cells. Free Radic Biol Med (2007) 0.90
The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J Lipid Res (2008) 0.90
Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels. Lipids Health Dis (2011) 0.90
The SCARB1 gene is associated with lipid response to dietary and pharmacological interventions. J Hum Genet (2008) 0.90
Age and vitamin E-induced changes in gene expression profiles of T cells. J Immunol (2006) 0.90
Mechanism of action of recombinant acc-royalisin from royal jelly of Asian honeybee against gram-positive bacteria. PLoS One (2012) 0.89
Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis (2002) 0.89
Sarcoplasmic reticulum Ca(2+) pump mRNA stability in cardiac and smooth muscle: role of the 3'-untranslated region. Am J Physiol Cell Physiol (2002) 0.89
Curcumin-supplemented diets increase superoxide dismutase activity and mean lifespan in Drosophila. Age (Dordr) (2012) 0.89
Genome-wide linkage analyses and candidate gene fine mapping for HDL3 cholesterol: the Framingham Study. J Lipid Res (2005) 0.89
Modulation by dietary fat and carbohydrate of IRS1 association with type 2 diabetes traits in two populations of different ancestries. Diabetes Care (2013) 0.89
Mesencephalic astrocyte-derived neurotrophic factor inhibits oxygen-glucose deprivation-induced cell damage and inflammation by suppressing endoplasmic reticulum stress in rat primary astrocytes. J Mol Neurosci (2013) 0.88
Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants. Atherosclerosis (2010) 0.88
Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis (2005) 0.88
Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma. Cancer (2004) 0.88
Perilipin polymorphism interacts with dietary carbohydrates to modulate anthropometric traits in hispanics of Caribbean origin. J Nutr (2008) 0.88
CRY1 circadian gene variant interacts with carbohydrate intake for insulin resistance in two independent populations: Mediterranean and North American. Chronobiol Int (2014) 0.88
Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate. Pharmacogenet Genomics (2012) 0.87
Modulation of gene expression by α-tocopherol and α-tocopheryl phosphate in THP-1 monocytes. Free Radic Biol Med (2010) 0.87
Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice. J Nutr Biochem (2011) 0.87
Liquid chromatography-mass spectrometry methods for urinary biomarker detection in metabonomic studies with application to nutritional studies. Biomed Chromatogr (2010) 0.86
Adaptive genetic variation and heart disease risk. Curr Opin Lipidol (2010) 0.86
Genetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study. Lipids (2012) 0.86
Genetic polymorphisms as determinants for disease-preventive effects of vitamin E. Nutr Rev (2008) 0.86
CCL20 Secretion from the Nucleus Pulposus Improves the Recruitment of CCR6-Expressing Th17 Cells to Degenerated IVD Tissues. PLoS One (2013) 0.85
Curcumin and aging. Biofactors (2013) 0.85
Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.85
Molecular characterization of the recombinant iron-containing alcohol dehydrogenase from the hyperthermophilic Archaeon, Thermococcus strain ES1. Extremophiles (2008) 0.84
The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate. J Cardiovasc Pharmacol (2012) 0.84
Gene-centric meta-analyses for central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations. Hum Mol Genet (2013) 0.84
Clustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapy. PLoS One (2012) 0.84
Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study. Am J Clin Nutr (2009) 0.84
Apolipoprotein A2 polymorphism interacts with intakes of dairy foods to influence body weight in 2 U.S. populations. J Nutr (2013) 0.84
Apolipoprotein A5 and lipoprotein lipase interact to modulate anthropometric measures in Hispanics of Caribbean origin. Obesity (Silver Spring) (2009) 0.83
Interactions between genetic variants of folate metabolism genes and lifestyle affect plasma homocysteine concentrations in the Boston Puerto Rican population. Public Health Nutr (2011) 0.83